Bio-Ved Pharmaceuticals Private Limited

Bio-Ved Pharmaceuticals Private Limited - pharma in Pune, Maharashtra, India. FY 2026 financials & compliance.
CIN U24239MH1995PTC094274 Incorporated 08 November 1995 ROC Pune HQ Pune, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹1.01 Cr
▼ 38% YoY
Net loss · FY 2024
₹28.2 Lakh
Net margin -28%
EBITDA · FY 2024
₹3.32 Lakh
EBITDA margin 3.3%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹2.87 Cr
Issued & subscribed
Satisfied charges
₹20 Lakh
No open charges
Company age
31 yrs
Est. 1995
Employees · EPFO
5
Provident fund records

About Bio-Ved Pharmaceuticals Private Limited

Data last updated:

Bio-Ved Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India, a subsidiary of Bioved Pharmaceuticals Inc.. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 November 1995 and has been in existence for over 31 years.

The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24239MH1995PTC094274. Its GSTIN is 27AABCB1578N1ZC (Maharashtra).

The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹2.87 Cr. It is led by directors Deeplaxmi Sanjeev Chitre and Ajit Prabhakar Chitre.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit No. 5 & 6 Survey No. 12( Part) Near Lokmat Vadgaon Khurd, Pune, Maharashtra, India – 411041.

As per the financials filed for FY 2024, the company reported a revenue of ₹1.01 Cr, a decline of 38% compared to the previous year. For the same year it recorded a net loss of ₹28.2 Lakh (net margin -28%) and EBITDA of ₹3.32 Lakh (EBITDA margin 3.3%). Revenue has declined at a compounded annual rate (CAGR) of 12% over three years and 12% over five years.

The company has about 5 employees on its provident fund (EPFO) records.

As per MCA filings, the company has satisfied charges of ₹20 Lakh on record. Court records list 5 cases involving the company, including 3 filed by the company and 2 filed against it.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24239MH1995PTC094274
Registration Number 094274
Incorporation Date 08 November 1995
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Bioved Pharmaceuticals Inc.
Compliance Status Active Compliant

Contact details

Bio-Ved Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Unit No. 5 & 6 Survey No. 12( Part) Near Lokmat Vadgaon Khurd, Pune, Maharashtra, India – 411041
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Bio-Ved Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Bio-Ved Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Bio-Ved Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Bio-Ved Pharmaceuticals Private Limited, buy the company report.

Financials of Bio-Ved Pharmaceuticals Private Limited

FY 2025 filings available

Bio-Ved Pharmaceuticals Private Limited reported revenue of ₹1.01 Cr (down 38% YoY) for FY 2024.

Revenue · FY 2024
₹1.01 Cr ▼ 38%
Net loss · FY 2024
₹28.2 Lakh margin -28%
EBITDA · FY 2024
₹3.32 Lakh margin 3.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 38%
3 years · compounded
▼ 12%
5 years · compounded
▼ 12%
EBITDA CAGR growth
1 year
▼ 93%
3 years · compounded
▲ 28%
5 years · compounded
▼ 26%

Revenue has declined at a compounded annual rate (CAGR) of 12% over five years, including a 38% fall in the latest year. EBITDA fell 93% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹3.32 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹28.2 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin3.3%
Net Profit Margin-28%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Bio-Ved Pharmaceuticals Private Limited, buy the company report.

Board of directors of Bio-Ved Pharmaceuticals Private Limited

Bio-Ved Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Deeplaxmi Sanjeev ChitreDirector08 Nov 199530 Years 11 MonthsCurrent
Ajit Prabhakar ChitreDirector16 Feb 20224 Years 8 MonthsCurrent

Peer comparison

Bio-Ved Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
John Biotech Private Limited₹1.01 Cr (FY 2025)-3.0%Ahmedabad, Gujarat, India
Bio-Ved Pharmaceuticals Private Limitedthis company₹1.01 Cr (FY 2024)-₹28.2 Lakh-28%-38.0%5Pune, Maharashtra, India
Rose Pharmaceuticals and Healthcare Private Limited₹1.01 Cr (FY 2024)-1.0%R S Naidunagar, Karnataka, India
Nityam Dipakam Pharmaceuticals Private Limited₹1.01 Cr (FY 2025)2.0%Kolhapur, Maharashtra, India

To see the full peer comparison of Bio-Ved Pharmaceuticals Private Limited, buy the company report.

Auditor

Bio-Ved Pharmaceuticals Private Limited is audited by P P B AND ASSOCIATES for the financial year 2019.

Auditor firmFinancial yearFirm registration number
P P B AND ASSOCIATESFY 2019141920W

Shareholding

The shareholding of Bio-Ved Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Bio-Ved Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹20 Lakh
Breakdown by lending institutions
Bank of India₹0.20 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
26 May 200810107356Bank of India₹20 LakhSatisfied

To see the full charge records of Bio-Ved Pharmaceuticals Private Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Bio-Ved Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Bio-Ved Pharmaceuticals Private Limited has a workforce of 5 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.

Employee count
5
Active EPFO establishments
1

GST

Bio-Ved Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AABCB1578N1ZCMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Bio-Ved Pharmaceuticals Private Limited, buy the company report.

Recent activity

Bio-Ved Pharmaceuticals Private Limited has 5 board changes on record since 1995: 2 appointments and 3 cessations. The latest: Susheel Ramesh Sule ceased to be Director on 30 Apr 2025.

AGM
Bio-Ved Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Susheel Ramesh Sule ceased to be Director.
Filing
Bio-Ved Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Ceased
Dilip Parshuram Vaidya ceased to be Director.
Charges
A charge registered on 26 May 2008 via Charge ID 10107356 with Bank Of India was fully satisfied on 08 Apr 2022.
Appointed
Ajit Prabhakar Chitre was appointed as Director.
Ceased
Ajit Prabhakar Chitre ceased to be Director.
Charges
A charge with Bank Of India amounted to Rs. 0.20 Cr with Charge ID 10107356 was registered on 26 May 2008.
Appointed
Deeplaxmi Sanjeev Chitre was appointed as Director.
Incorporation
08 Nov 1995
Bio-Ved Pharmaceuticals Private Limited was registered on 08 Nov 1995 with Roc Pune & aged 30 years 11 months as per MCA records.

Frequently asked questions

Bio-Ved Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 November 1995 (31+ years old) and is registered under CIN U24239MH1995PTC094274.

Bio-Ved Pharmaceuticals has 2 current directors:

The latest financial statements of Bio-Ved Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Bio-Ved Pharmaceuticals is 27AABCB1578N1ZC, registered in Maharashtra.

The CIN (Corporate Identification Number) of Bio-Ved Pharmaceuticals is U24239MH1995PTC094274. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Bio-Ved Pharmaceuticals has 5 court cases on record: 3 filed by the company and 2 filed against it. Most are in the district courts.

Bio-Ved Pharmaceuticals was incorporated on 08 November 1995, making it 31+ years old. It is registered with the Registrar of Companies, Pune.

The peers of Bio-Ved Pharmaceuticals by revenue are John Biotech Private Limited, Rose Pharmaceuticals and Healthcare Private Limited, Nityam Dipakam Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Susheel Ramesh Sule ceased to be Director on 30 Apr 2025. Dilip Parshuram Vaidya ceased to be Director on 01 Jan 2024. Ajit Prabhakar Chitre was appointed as Director on 16 Feb 2022. Bio-Ved Pharmaceuticals has 5 board changes on record in total.

The registered office of Bio-Ved Pharmaceuticals is at Unit No. 5 & 6 Survey No. 12 Part Near Lokmat Vadgaon Khurd, Pune, Maharashtra, India – 411041.

Bio-Ved Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.